Emergency Management of Acute Left Upper Extremity Weakness and Numbness
Activate emergency medical services immediately and transport directly to the nearest stroke-capable center with CT imaging, as this presentation is acute ischemic stroke until proven otherwise, and every 15-minute delay in treatment increases mortality by 5%. 1, 2
Immediate Prehospital Actions (Target ≤15 Minutes On-Scene)
Time is brain—the single most critical piece of information is determining the exact time the patient was last known to be neurologically normal. 1, 3 This "last known well" time determines all treatment eligibility, not when symptoms were discovered.
On-Scene Assessment and Stabilization
- Assess airway, breathing, and circulation first—intubate only if Glasgow Coma Scale ≤8 or the patient cannot protect their airway. 4, 3
- Check fingerstick glucose immediately—if <60 mg/dL, administer IV dextrose, as hypoglycemia mimics stroke and contraindicates thrombolysis. 4, 1, 3
- Establish IV access with normal saline (avoid dextrose-containing fluids in non-hypoglycemic patients) and draw blood samples for CBC, electrolytes, creatinine, PT/INR, aPTT. 4, 3
- Provide supplemental oxygen only if oxygen saturation <94%—routine oxygen does not improve outcomes. 4, 1, 3
- Do NOT treat blood pressure in the field unless systolic BP ≥220 mmHg, and only after consulting medical command—permissive hypertension maintains cerebral perfusion. 4, 1, 3
Critical Documentation
- Record the exact "last known well" time (when the patient was last observed normal, not when symptoms were discovered). 1, 3
- Document any anticoagulant use (warfarin, direct oral anticoagulants) or recent antiplatelet therapy, as these affect reperfusion eligibility. 3
- Perform a rapid stroke severity assessment using NIHSS or similar validated scale to identify potential large-vessel occlusion. 1, 2, 3
Transport Protocol
Bypass non-stroke hospitals and transport directly to the nearest primary stroke center or comprehensive stroke center. 4, 3 Provide detailed pre-notification including:
- Last known well time 3
- Current neurological deficits and stroke scale score 3
- Vital signs, oxygen saturation, and glucose level 3
- Anticoagulation status 3
- Estimated time of arrival 3
Limit on-scene time to ≤15 minutes—defer non-essential interventions to the transport phase. 3
Hospital Emergency Department Management
Immediate Diagnostic Workup (Door-to-Imaging ≤25 Minutes)
- Non-contrast head CT within 25 minutes of arrival to exclude hemorrhage and identify early ischemic changes. 1, 2
- CT interpretation within 45 minutes for thrombolytic candidates. 1, 2
- Add CT angiography if the patient presents within 6 hours to identify large-vessel occlusion for potential endovascular thrombectomy. 1, 3
- Do NOT delay IV thrombolysis to obtain advanced imaging (perfusion CT or MRI)—rapid treatment supersedes additional imaging. 1
Intravenous Thrombolysis (Door-to-Needle ≤30 Minutes)
Intravenous alteplase 0.9 mg/kg (maximum 90 mg) is the single most beneficial proven intervention for acute ischemic stroke and must be administered within 3-4.5 hours of symptom onset. 4, 1, 5
Pre-Treatment Blood Pressure Requirements
- Reduce BP to <185/110 mmHg BEFORE starting alteplase using labetalol 10 mg IV or nicardipine infusion (starting at 5 mg/h, titrated by 2.5 mg/h every 5-15 minutes, maximum 15 mg/h). 1, 3
- Maintain BP ≤180/105 mmHg during and for 24 hours after alteplase infusion. 1, 3
Dosing Protocol
- 10% of total dose as IV bolus over 1 minute, remaining 90% infused over 60 minutes. 1
- Do NOT administer aspirin within 24 hours of alteplase—this increases hemorrhage risk. 1
Endovascular Thrombectomy (Door-to-Groin ≤90 Minutes)
Consider mechanical thrombectomy with stent retrievers for large-vessel occlusion if all criteria are met: 1, 2
- Pre-stroke modified Rankin Scale 0-1
- Large-vessel occlusion confirmed on CT angiography
- NIHSS ≥6
- ASPECTS ≥6
- Groin puncture possible within 6 hours of symptom onset (up to 24 hours for selected patients meeting advanced imaging criteria)
The "drip-and-ship" model is appropriate—administer IV alteplase at the primary stroke center and immediately transfer for thrombectomy without waiting to assess alteplase effect. 3
Blood Pressure Management (Non-Thrombolysis Candidates)
For patients NOT receiving thrombolysis, practice permissive hypertension unless systolic BP >220 mmHg or diastolic BP >120 mmHg. 1 Aggressive BP lowering may worsen cerebral perfusion to the ischemic penumbra.
- If BP ≥220/120 mmHg, reduce by only 15% during the first 24 hours. 1
- Avoid lowering BP <185/110 mmHg in the acute phase unless thrombolysis is planned. 1
Antiplatelet Therapy
Start aspirin 325 mg within 24-48 hours after stroke onset (or after repeat CT if thrombolysis was given) to reduce early recurrent stroke risk. 1 This timing is Class I, Level A evidence.
- Wait 24 hours after alteplase and obtain repeat head CT to exclude hemorrhage before starting aspirin. 1
- Aspirin is NOT a substitute for IV alteplase in eligible patients. 1
- Clopidogrel alone or dual antiplatelet therapy is NOT recommended for acute ischemic stroke (Class III, Level C). 1
Anticoagulation in the Acute Phase
Do NOT use full-dose unfractionated heparin or low-molecular-weight heparin for acute ischemic stroke—they do not improve outcomes and increase hemorrhage risk (Class III, Level A). 1 Emergency anticoagulation does not lower the risk of early recurrent stroke, even in cardioembolic sources. 1
Hospital Admission and Monitoring
Admit to a dedicated stroke unit with monitored beds for at least 24 hours—stroke unit care reduces mortality and morbidity comparably to the effects of alteplase itself. 4, 1
Supportive Care
- Maintain oxygen saturation ≥94% using pulse oximetry; provide supplemental oxygen only when saturation falls below this threshold. 1
- Check core temperature every 4 hours for the first 48 hours and treat fever promptly (target ≤37.5°C)—fever worsens neurological damage. 1
- Begin intermittent pneumatic compression devices within 24 hours for VTE prophylaxis in immobile patients. 1
- Assess swallowing before any oral intake to prevent aspiration. 1
- Initiate early mobilization within 24 hours (sitting, standing, brief ambulation) if no contraindications exist. 1
Critical Time-Dependent Outcomes
Every 15-minute reduction in door-to-needle time decreases in-hospital mortality by 5%. 1, 3 Every 30-minute delay in reperfusion reduces the probability of favorable outcome by 10.6%. 1
Treatment within 90 minutes of onset is most likely to result in favorable outcomes, with 37% of patients recovering to fully independent function when guidelines are followed. 1
Common Pitfalls to Avoid
- Never delay transport to obtain imaging at a non-CT facility—rapid transport supersedes any on-site intervention without imaging. 3
- Do not withhold treatment for "mild" or improving symptoms—large-vessel occlusions can present with fluctuating deficits. 3
- Never aggressively lower BP in acute stroke unless giving thrombolytics or BP >220/120 mmHg—permissive hypertension maintains penumbral perfusion. 1
- Do not assume patients beyond 4.5 hours are ineligible—endovascular treatment may be offered up to 24 hours with appropriate imaging selection. 3
- Emergency carotid endarterectomy is generally NOT performed for acute ischemic stroke due to high risk of adverse events, especially when the deficit is large. 4